ロード中...
Pan-Bcl-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells
Pancreatic cancer is a deadly disease and has the worst prognosis among almost all cancers and is in dire need of new and improved therapeutic strategies. Conditioning of tumor cells with chemotherapeutic drug has been shown to enhance the anti-tumor effects of cancer vaccines and adoptive cell ther...
保存先:
主要な著者: | , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
Public Library of Science
2012
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3501501/ https://ncbi.nlm.nih.gov/pubmed/23185240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0047520 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|